Prognostic factors in head and neck cancer

By van den Brekel M.W.M.   Bindels E.M.J.   Balm A.J.M.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1041-1043

Elsevier

Access to resources Recommend Favorite

Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck

By Kandiloros D.   Eleftheriadou A.   Chalastras T.   Kyriou L.   Yiotakis I.   Ferekidis E.  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 463-470

Humana Press, Inc

Access to resources Recommend Favorite

Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan

By Nishimura Kazuo  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 306-313

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility of concervative breast surgery and intraoperative radiation therapy for early breast cancer: A single-center, open, non-randomized, prospective pilot study

By                    

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1539-1546

Spandidos Publications

Access to resources Recommend Favorite

A qualitative study of head and neck cancer

By Moore R.  

Supportive Care in Cancer, Vol. 12, Iss. 5, 2004-05 ,pp. : 338-346

Springer Publishing Company

Access to resources Recommend Favorite